EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Acute myocardial infarction induced by avatrombopag: a case report

Gou Junqi, Liu Chaohui, Lang Mingjian, Yao Fengyou

Frontiers in Pharmacology · 22.08.2025 · 16

DOI: 10.3389/fphar.2025.1618693 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Frontiers in Pharmacology, online erschienen am 22.08.2025. Verfasst von Gou Junqi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Geriatric Diseases Institute of Chengdu/Cancer Prevention and Treatment Institute of Chengdu, Chengdu Fifth People's Hospit…. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Avatrombopag, a thrombopoietin receptor agonist (TPO-RA), is used for immune thrombocytopenia (ITP) but confers thrombotic risks. Acute myocardial infarction (AMI) as an adverse event is underreported. Summary A 58-year-old female with steroid-refractory ITP developed ST-elevation myocardial infarction (STEMI) 5 days after initiating avatrombopag monotherapy (20 mg/day). She had no history of traditional cardiovascular risk factors. Her platelet count increased from two to 122 × 10 9 /L before AMI. Coronary angiography revealed thrombotic occlusion of the left ventricular posterior branch, treated with thrombus aspiration. Dual antiplatelet therapy was initiated, and avatrombopag was discontinued. The patient was discharged on day 10 post-AMI. At the 14-day follow-up, thrombocytopenia recurred (platelets 18 × 10 9 /L), requiring avatrombopag re-initiation alongside aspirin. No further thrombosis occurred.

Conclusion

Avatrombopag monotherapy may induce rapid coronary thrombosis. Prophylactic antiplatelet therapy and maintaining platelets at 50–150 × 10 9 /L are critical during TPO-RA treatment. This case highlights the need for thrombotic risk assessment before TPO-RA initiation.

Schlagwörter

Stichwörter der Autor:innen

acute myocardial infarctionavatrombopagcoronary thrombosisimmune thrombocytopeniathrombopoietin receptor agonists

Autor:innen und Institutionen

  • Department of Cardiology, Geriatric Diseases Institute of Chengdu/Cancer Prevention and Treatment Institute of Chengdu, Chengdu Fifth People's Hospital (The Second Clinical Medical College, Affiliated Fifth People's Hos…

Zitieren

APA

Junqi, G., Chaohui, L., Mingjian, L., & Fengyou, Y. (2025). Acute myocardial infarction induced by avatrombopag: a case report. Frontiers in Pharmacology, 16. https://doi.org/10.3389/fphar.2025.1618693

Vancouver

Junqi G, Chaohui L, Mingjian L, Fengyou Y. Acute myocardial infarction induced by avatrombopag: a case report. Frontiers in Pharmacology. 2025;16. doi:10.3389/fphar.2025.1618693

BibTeX
@article{Junqi2025,
  author = {Junqi, Gou and Chaohui, Liu and Mingjian, Lang and Fengyou, Yao},
  title = {Acute myocardial infarction induced by avatrombopag: a case report},
  journal = {Frontiers in Pharmacology},
  year = {2025},
  volume = {16},
  doi = {10.3389/fphar.2025.1618693}
}
Kostenlos starten →